Art. 55 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 7×
1.

The particulars laid down in Article 54 shall appear on immediate packagings other than those referred to in paragraphs 2 and 3.

2.

The following particulars at least shall appear on immediate packagings which take the form of blister packs and are placed in an outer packaging that complies with the requirements laid down in Articles 54 and 62.

the name of the medicinal product as laid down in point (a) of Article 54,

the name of the holder of the authorization for placing the product on the market,

the expiry date,

the batch number.

3.

The following particulars at least shall appear on small immediate packaging units on which the particulars laid down in Articles 54 and 62 cannot be displayed:

the name of the medicinal product as laid down in point (a) of Article 54 and, if necessary, the route of administration,

the method of administration,

the expiry date,

the batch number,

the contents by weight, by volume or by unit.

  • Directive (EU) 2004/27Lawamends

  • Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 Novembe…1112Law

    Чрез дерогация от разпоредбите на член 54 и член 55, параграф 1 от Директива 2001/83/ЕО изброените в приложение III към настоящия …

  • BGH, Urteil vom 30. März 2017 - I ZR 263/15Decision

    … zugelassenen Arzneimitteln die Angaben "Ch.-B." und "verwendbar bis" im Hinblick darauf entbehrlich seien, dass Art. 55 Abs. 3 der Richtlinie 2001/83/EG bei kleinen Primärverpackungen weder für die Angabe des Verfalldatums noch für die …

    30 Mar 2017 · KORE318682017

  • Opinion of Advocate General Szpunar delivered on 13 January 2022. Novartis Pharma GmbH v Abacus Medicine A/S.Decision

    Second, if the parallel trader is entitled to repackage a medicinal product without the opposition of the trade mark proprietor, that is conditional on the immediate packaging being left intact. [Judgment in Hoffmann-La Roche (paragraph …

    13 Jan 2022 · 62020CC0147

  • Opinion of Advocate General Szpunar delivered on 11 June 2026.Decision

    … по член 10, параграф 1 и параграф 8, трето изречение от AMG и по член 55, параграф 3 от Директива 2001/83 са предназначени не да защитават …

    11 Jun 2026 · 62025CC0354

  • BVerwG, EuGH-Vorlage vom 20. März 2025 - 3 C 9/23Decision

    … 267 AEUV vorgelegt: 1. Finden die Kennzeichnungsvorgaben der Art. 54, 55 Abs. 3 und Art. 63 Abs. 1 der Richtlinie 2001/83/EG auf ein Arzneimittel Anwendung, für das in einem Mitgliedstaat eine Genehmigung für das Inverkehrbringen erteilt …

    20 Mar 2025 · WBRE202500338

  • BGH, Urteil vom 30. März 2017 - I ZR 263/15Decision

    30 Mar 2017 · I_ZR_263-15